Pharmacy World and Science

, Volume 26, Issue 1, pp 3–5 | Cite as

Is it time to change diabetic disease nomenclature?

  • Abduelmula R. Abduelkarem
  • Mike A. Sackville
  • Rae M. Morgan
  • Anthony J. Hildreth


The study explored the confusion in diabetes terminology as illustrated by the use of insulin in NIDDM. It is proposed that a new terminology for both types of diabetes be introduced. In order to investigate this proposal, we invited a total of 84 medical professionals to contribute their views via a one-page questionnaire, personally handed to the participants. Considering the variety of terms in the sample polled for this study, and the fact that patients with type 2 diabetes might need insulin management at any stage of their life, some professionals persist in using the old names, a fact that seems to fly in the face of logic. Most pharmacists will be aware that not only are the professionals confused by the current situation but that patients are also perplexed when, for example, receiving treatment with insulin after being told that they have non-insulin dependent diabetes.

Diabetes mellitus Diabetes nomenclature Medical professionals Pharmacists Questionnaire 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Health Organisation Study Group. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva: Report of a WHO Consultation, 1999 (Part 1).Google Scholar
  2. 2.
    The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2000; 23(Suppl 1): S4–S23.Google Scholar
  3. 3.
    Meltzer S, Leiter L, Daneman D, Gertein HC, Lau D, Ludwig S et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998; 159(Suppl 8): S1–S29.Google Scholar
  4. 4.
    Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care 1999; 22: 345–54.Google Scholar
  5. 5.
    Ehtisham S, Barrett TG, Shaw NJ. Type 2 diabetes mellitus in UK children — an emerging problem. Diabet Med 2000; 17: 867–71.Google Scholar
  6. 6.
    Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002; 346: 802–10.Google Scholar
  7. 7.
    Scheen AJ, Lefebvre PJ. Oral antidiabetic agents: a guide to selection. Drugs 1998; 55: 225–36.Google Scholar
  8. 8.
    Clark CM, Perry RC. Type 2 diabetes and macrovascular disease: epidemiology and etiology. Am Heart J 138(5 Suppl 1): S331–3.Google Scholar
  9. 9.
    Rae CE, Ewing RC, Cook DD. Inappropriate use of high dose glyburide to treat uncontroled type 2 diabetes mellitus. Ann Pharmacother 1993; 27: 161–6.Google Scholar
  10. 10.
    Yap WS, Peterson GM, Vial JH, Randall CTC, Greenaway TM. Review of management of type 2 diabetes mellitus. J Clin Pharm Ther 1998; 23: 457–65.Google Scholar
  11. 11.
    Singh BM, Prescott JW, Guy R, Walford S, Murphy M, Wise PH. Effect of advertising on awareness of symptoms of diabetes among the general public: the British Diabetic Association. BMJ 1994; 308: 632–6.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Abduelmula R. Abduelkarem
    • 1
  • Mike A. Sackville
    • 2
  • Rae M. Morgan
    • 2
  • Anthony J. Hildreth
    • 3
  1. 1.Clinical Pharmacy Department, Faculty of Pharmacy and Health ScienceAjman University of Science and TechnologyAjmanUAE
  2. 2.Pharmacy Practice Department, Sunderland School of PharmacyUniversity of SunderlandSunderlandUK
  3. 3.City Hospitals Sunderland, Sunderland Royal HospitalSunderland Royal HospitalSunderlandUK

Personalised recommendations